Examining FKBP5 mRNA expression in human iPSC-derived neural cells

Psychiatry Research

Volumn 247, Issue , 2017, Pages 172-181

  Lieberman, Richard ^a   Kranzler, Henry R ^b,c   Levine, Eric S ^a   Covault, Jonathan ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fibroblasts; FK506 Binding Protein 51; Gene expression; Glucocorticoid receptor; Induced pluripotent stem cells; Neural differentiation; rs1360780

Indexed keywords

GLUCOCORTICOID RECEPTOR; MESSENGER RNA; POTASSIUM CHLORIDE COTRANSPORTER 2; VESICULAR GLUTAMATE TRANSPORTER 1; DEXAMETHASONE; FK 506 BINDING PROTEIN; GLUCOCORTICOID; TACROLIMUS BINDING PROTEIN 5;

ACTION POTENTIAL; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FKBP5 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INDUCED PLURIPOTENT STEM CELL; MALE; MEMBRANE STEADY POTENTIAL; NEURAL STEM CELL; NR3C1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RBFOX3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC12A5 GENE; SLC17A7 GENE; DRUG EFFECTS; GENETICS; GENOTYPE; METABOLISM; PHYSIOLOGY;

DEXAMETHASONE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURAL STEM CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TACROLIMUS BINDING PROTEINS;

EID: 84999751178     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.11.027     Document Type: Article

References (58)

1. Bar-Nur, O., Russ, H.A., Efrat, S., Benvenisty, N., Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9 (2011), 17–23.
2. Binder, E.B., The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34:Suppl. 1 (2009), S186–S195.
3. Binder, E.B., Bradley, R.G., Liu, W., Epstein, M.P., Deveau, T.C., Mercer, K.B., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299 (2008), 1291–1305.
4. Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Putz, B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36 (2004), 1319–1325.
5. Brennand, K., Savas, J.N., Kim, Y., Tran, N., Simone, A., Hashimoto-Torii, K., et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20 (2015), 361–368.
6. Carey, B.W., Markoulaki, S., Hanna, J.H., Faddah, D.A., Buganim, Y., Kim, J., et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9 (2011), 588–598.
7. De Kloet, E.R., Hormones and the stressed brain. Stress.: Curr. Neuroendocr. Genet. Approaches 1018 (2004), 1–15.
8. de Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 (2005), 463–475.
9. Ebrecht, M., Buske-Kirschbaum, A., Hellhammer, D., Kern, S., Rohleder, N., Walker, B., et al. Tissue specificity of glucocorticoid sensitivity in healthy adults. J. Clin. Endocrinol. Metab. 85 (2000), 3733–3739.
10. Ellis, F.W., Effect of ethanol on plasma corticosterone levels. J. Pharm. Exp. Ther. 153 (1966), 121–127.
11. Fani, N., Gutman, D., Tone, E.B., Almli, L., Mercer, K.B., Davis, J., et al. FKBP5 and attention bias for threat: associations with hippocampal function and shape. JAMA Psychiatry 70 (2013), 392–400.
12. Grabe, H.J., Wittfeld, K., Van der Auwera, S., Janowitz, D., Hegenscheid, K., Habes, M., et al. Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample. Hum. Brain Mapp. 37 (2016), 1602–1613.
13. Grad, I., Picard, D., The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell Endocrinol. 275 (2007), 2–12.
14. Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., et al. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int. J. Neuropsychopharmacol. 18 (2015), 1–9.
15. Holz, N.E., Buchmann, A.F., Boecker, R., Blomeyer, D., Baumeister, S., Wolf, I., et al. Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume. Brain Struct. Funct. 220:3 (2015), 1355–1368.
16. Hsieh, J., Gage, F.H., Epigenetic control of neural stem cell fate. Curr. Opin. Genet. Dev. 14 (2004), 461–469.
17. Huang, M.C., Schwandt, M.L., Chester, J.A., Kirchhoff, A.M., Kao, C.F., Liang, T., et al. FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout mice. Neuropsychopharmacology 39 (2014), 2029–2038.
18. Ing, N.H., Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 72 (2005), 1290–1296.
19. Ing, N.H., Forrest, D.W., Riggs, P.K., Loux, S., Love, C.C., Brinsko, S.P., et al. Dexamethasone acutely down-regulates genes involved in steroidogenesis in stallion testes. J. Steroid Biochem. Mol. Biol. 143 (2014), 451–459.
20. Jensen, K.P., Herman, A.I., Morean, M.E., Kranzler, H.R., Gelernter, J., Sofuoglu, M., FKBP5 variation is associated with the acute and chronic effects of nicotine. Pharmacogenomics J. 15 (2015), 340–346.
21. Kang, J.I., Chung, H.C., Jeung, H.C., Kim, S.J., An, S.K., Namkoong, K., FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study. Psychoneuroendocrinology 37 (2012), 1569–1576.
22. Kerns, R.T., Ravindranathan, A., Hassan, S., Cage, M.P., York, T., Sikela, J.M., et al. Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J. Neurosci. 25 (2005), 2255–2266.
23. Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J.C., Pariante, C.M., et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 16 (2013), 33–41.
24. Kranzler, H.R., Covault, J., Feinn, R., Armeli, S., Tennen, H., Arias, A.J., et al. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am. J. Psychiatry 171 (2014), 445–452.
25. Lavebratt, C., Aberg, E., Sjoholm, L.K., Forsell, Y., Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J. Affect. Disord. 125 (2010), 249–255.
26. Lee, R.S., Tamashiro, K.L., Yang, X., Purcell, R.H., Harvey, A., Willour, V.L., et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 151 (2010), 4332–4343.
27. Lemtiri-Chlieh, F., Levine, E.S., BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. J. Neurophysiol. 104 (2010), 1923–1932.
28. Levran, O., Randesi, M., Li, Y., Rotrosen, J., Ott, J., Adelson, M., et al. Drug addiction and stress-response genetic variability: association study in African Americans. Ann. Hum. Genet. 78 (2014), 290–298.
29. Lieberman, R., Kranzler, H.R., Joshi, P., Shin, D.G., Covault, J., GABRA2 alcohol dependence risk allele is associated with reduced expression of chromosome 4p12 GABAA subunit genes in human neural cultures. Alcohol Clin. Exp. Res. 39 (2015), 1654–1664.
30. Lieberman, R., Levine, E.S., Kranzler, H.R., Abreu, C., Covault, J., Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. Alcohol Clin. Exp. Res. 36 (2012), 1678–1687.
31. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471 (2011), 68–73.
32. Lovallo, W.R., Dickensheets, S.L., Myers, D.A., Thomas, T.L., Nixon, S.J., Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin. Exp. Res. 24 (2000), 651–658.
33. Luijk, M.P., Velders, F.P., Tharner, A., van Ijzendoorn, M.H., Bakermans-Kranenburg, M.J., Jaddoe, V.W., et al. FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction. Psychoneuroendocrinology 35 (2010), 1454–1461.
34. Mahon, P.B., Zandi, P.P., Potash, J.B., Nestadt, G., Wand, G.S., Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults. Psychopharmacology 227 (2013), 231–241.
35. McClintick, J.N., Xuei, X., Tischfield, J.A., Goate, A., Foroud, T., Wetherill, L., et al. Stress-response pathways are altered in the hippocampus of chronic alcoholics. Alcohol 47 (2013), 505–515.
36. Menke, A., Arloth, J., Putz, B., Weber, P., Klengel, T., Mehta, D., et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 37 (2012), 1455–1464.
37. Mertens, J., Marchetto, M.C., Bardy, C., Gage, F.H., Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat. Rev. Neurosci. 17 (2016), 424–437.
38. Mertens, J., Paquola, A.C., Ku, M., Hatch, E., Bohnke, L., Ladjevardi, S., et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17 (2015), 705–718.
39. Mertens, J., Wang, Q.W., Kim, Y., Yu, D.X., Pham, S., Yang, B., et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 527 (2015), 95–99.
40. Milivojevic, V., Feinn, R., Kranzler, H.R., Covault, J., Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3alpha-HSD type 2 (17beta-HSD type 5), moderates the subjective effects of alcohol. Psychopharmacology 231 (2014), 3597–3608.
41. Perez-Ortiz, J.M., Garcia-Gutierrez, M.S., Navarrete, F., Giner, S., Manzanares, J., Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 38 (2013), 1251–1258.
42. Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D., Enoch, M.A., Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35 (2010), 1674–1683.
43. Scharf, S.H., Liebl, C., Binder, E.B., Schmidt, M.V., Muller, M.B., Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One, 6, 2011, e16883.
44. Schatzberg, A.F., Keller, J., Tennakoon, L., Lembke, A., Williams, G., Kraemer, F.B., et al. HPA axis genetic variation, cortisol and psychosis in major depression. Mol. Psychiatry 19 (2014), 220–227.
45. Schuster, J., Halvardson, J., Pilar Lorenzo, L., Ameur, A., Sobol, M., Raykova, D., et al. Transcriptome profiling reveals degree of variability in induced pluripotent stem cell lines: impact for human disease modeling. Cell Reprogram 17 (2015), 327–337.
46. Sinclair, D., Fillman, S.G., Webster, M.J., Weickert, C.S., Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness. Sci. Rep., 3, 2013, 3539.
47. Sinclair, D., Webster, M.J., Wong, J., Weickert, C.S., Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development. Mol. Psychiatry 16 (2011), 504–515.
48. Stechschulte, L.A., Sanchez, E.R., FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr. Opin. Pharmacol. 11 (2011), 332–337.
49. Sullivan, P.F., Fan, C., Perou, C.M., Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 141B (2006), 261–268.
50. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
51. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
52. Tatro, E.T., Everall, I.P., Kaul, M., Achim, C.L., Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 1286 (2009), 1–12.
53. Vermeer, H., Hendriks-Stegeman, B.I., van Suylekom, D., Rijkers, G.T., van Buul-Offers, S.C., Jansen, M., An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells. Mol. Cell Endocrinol. 218 (2004), 49–55.
54. Weickert, C.S., Webster, M.J., Boerrigter, D., Sinclair, D., FKBP5 messenger RNA increases after adolescence in human dorsolateral prefrontal cortex. Biol. Psychiatry, 2015.
55. White, M.G., Bogdan, R., Fisher, P.M., Munoz, K.E., Williamson, D.E., Hariri, A.R., FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity. Genes Brain Behav. 11 (2012), 869–878.
56. Yeo, S., Enoch, M.A., Gorodetsky, E., Ahktar, L., Schuebel, K., Roy, A., et al. The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure. Genes Brain Behav., 2016.
57. Yu, D.X., Di Giorgio, F.P., Yao, J., Marchetto, M.C., Brennand, K., Wright, R., et al. Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep. 2 (2014), 295–310.
58. Zannas, A.S., Binder, E.B., Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. Genes Brain Behav. 13 (2014), 25–37.